(REUTERS) - China-based staff of GlaxoSmithKline Plc allegedly handed doctors with cash and other rewards for prescribing Botox, according to the Wall Street Journal, in the latest scandal to hit the British drugmaker which is under investigation by Chinese police for economic crimes.
Internal documents and email showed GSK's China sales staff were also apparently instructed to use their personal email addresses to discuss marketing strategies related to Botox, the report added.
Citing an internal email dated May 13, a whistleblower notified GSK's board of directors and compliance officers of the allegations that its China sales staff bribed doctors to prescribe Botox over the past year, the paper reported on Sunday.
The same anonymous whistleblower earlier made allegations that GSK sales representatives in China were involved in widespread bribery to get doctors to prescribe the company's medicines, the report added.
http://www.straitstimes.com/breaking-news/asia
/story/new-bribery-allegations-hit-glaxosmithkline-china-report-20130708?
No comments:
Post a Comment